UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2021 | 2022-11-07 | Future report Set alerts | |
| Q2 2021 | 2022-08-15 | -0.54 | -0.54 |
| Q1 2022 | 2022-05-08 | Future report Set alerts | |
| Q4 2021 | 2022-03-11 | -0.47 | -0.47 |
| Q1 2021 | 2021-05-05 | 0.00 | 0.00 |
| Q4 2020 | 2021-02-19 | -0.27 | -0.27 |
| Q3 2020 | 2020-11-09 | -0.33 | 0.00 |
| Q2 2020 | 2020-08-04 | -0.36 | -0.36 |
| Q1 2020 | 2020-05-11 | -0.36 | -0.36 |
| Q4 2019 | 2020-03-03 | -0.41 | -0.41 |
| 2016-07-11 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-06-08 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-04-06 | Lower Price Target | FBR & Co. | Outperform | $21.00 to $16.00 |
| 2016-04-06 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-06 | Lower Price Target | FBR & Co | Outperform | $21.00 to $16.00 |
| 2016-04-05 | Lower Price Target | Rodman & Renshaw | Buy | $40.00 to $30.00 |
| 2016-03-21 | Reiterated Rating | Rodman & Renshaw | Buy | $40.00 |
| 2016-03-18 | Reiterated Rating | Brean Capital | Buy | $15.00 |
| 2016-03-16 | Lower Price Target | FBR & Co. | Outperform | $22.00 to $21.00 |
| 2016-03-07 | Reiterated Rating | Rodman & Renshaw | Buy | $40.00 |
| 2016-03-06 | Reiterated Rating | Brean Capital | Buy | $15.00 |
| 2016-02-29 | Lower Price Target | Rodman & Renshaw | Buy | $45.00 to $40.00 |
| 2016-01-27 | Reiterated Rating | FBR & Co. | Outperform | $22.00 |
| 2016-01-25 | Reiterated Rating | Brean Capital | Buy | $15.00 |
| 2016-01-13 | Reiterated Rating | FBR & Co. | Outperform | |
| 2015-12-28 | Initiated Coverage | FBR & Co. | Buy | |
| 2015-12-22 | Initiated Coverage | FBR & Co. | Outperform | $22.00 |
| 2015-12-07 | Reiterated Rating | Rodman & Renshaw | Buy | $45.00 |
| 2015-12-07 | Initiated Coverage | HC Wainwright | Buy | $45.00 |
| 2015-11-25 | Reiterated Rating | Buy | Buy | $26.00 to $15.00 |
| 2015-11-25 | Lower Price Target | Brean Capital | Buy | $26.00 to $15.00 |
| 2015-08-10 | Reiterated Rating | Brean Capital | Buy | $26.00 |
| 2015-08-03 | Initiated Coverage | MLV & Co. | Buy | $34.00 |
| 2015-07-29 | Boost Price Target | Brean Capital | Buy | $17.00 to $26.00 |
| 2015-07-10 | Reiterated Rating | HC Wainwright | Buy | $20.00 |
| 2015-06-30 | Reiterated Rating | MLV & Co. | Buy | $33.00 |
| 2015-06-22 | Reiterated Rating | MLV & Co. | Buy | $25.00 to $33.00 |
| 2015-05-28 | Initiated Coverage | Brean Capital | Buy | $17.00 |
| 2015-05-15 | Reiterated Rating | HC Wainwright | Buy | $20.00 |
| 2015-03-17 | Boost Price Target | HC Wainwright | Buy | $13.00 to $20.00 |
| 2014-12-19 | Set Price Target | HC Wainwright | Buy | $11.00 |
| 2014-12-19 | Set Price Target | MLV & Co. | Buy | $9.00 |
| 2014-12-15 | Reiterated Rating | Aegis | Buy | |
| 2014-10-02 | Initiated | H.C. Wainwright | Buy | $11 |
| 2014-10-02 | Initiated Coverage | HC Wainwright | Buy | $11.00 |
| 2014-06-19 | Initiated | MLV & Co | Buy | $9 |
| 2014-06-18 | Initiated Coverage | MLV & Co. | Buy | $9.00 |
| 2013-12-03 | Initiated Coverage | Capital Ideas Research | Buy | |
| 2013-12-03 | Initiated Coverage | Aegis | Buy | $40.00 |
| 2013-11-21 | Initiated | CRT Capital | Buy | $11 |
| 2013-11-20 | Initiated Coverage | CRT Capital | Buy | $11.00 |
| 2016-07-11 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-06-08 | Reiterated Rating | Rodman & Renshaw | Buy | |
| 2016-04-06 | Lower Price Target | FBR & Co. | Outperform | $21.00 to $16.00 |
| 2016-04-06 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-06 | Lower Price Target | FBR & Co | Outperform | $21.00 to $16.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SRNE 146 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| STATE STREET CORP | 40.67M |
| BlackRock Inc. | 34.18M |
| Vanguard Group, Inc | 22.52M |
| GEODE CAPITAL MANAGEMENT, LLC | 7.11M |
| D. E. Shaw & Co., Inc. | 5.06M |
| NORTHERN TRUST CORP | 3.44M |
| JPMORGAN CHASE & CO | 3.03M |
| Rafferty Asset Management, LLC | 2.99M |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 2.83M |
| CITIGROUP INC | 2.70M |
| CITADEL ADVISORS LLC | 2.12M |
| Nuveen Asset Management, LLC | 2.10M |
| BARCLAYS PLC | 2.00M |
| GOLDMAN SACHS GROUP INC | 1.94M |
| BANK OF AMERICA CORP /DE/ | 1.82M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Asia Pacific MedTech (BVI) Ltd | 30.20% (8617513) | SRNE / |
| Opko Health, Inc. | 7.55% (2153045) | SRNE / |
| Ji Henry Chief Scientific Officer & Sec | 6.68% (1906177) | SRNE / |
| ABG Management Ltd | 4.66% (1328529) | SRNE / |
| AFTING ERNST-GUENTER | 3.22% (917930) | ENTA / SQNM / SRNE / |
| Miao Zhenwei Chief Technology Officer | 1.96% (559390) | SRNE / |
| Uy George Chief Commercial Officer | 0.71% (201735) | SRNE / |
| SHAH JAISIM | 0.39% (112633) | PDLI / SRNE / |
| Ng George K See Remarks | 0.36% (101453) | SRNE / |
| Su Jeffrey Executive VP and COO | 0.05% (13000) | SRNE / |
| ZELDIS JEROME B See Remarks | 0.04% (10000) | ALQA / PTCT / SNGX / SRNE / |
| Herde Kevin Executive VP and CFO | 0.02% (7000) | SRNE / |
| Wu Yue Alexander | 0.02% (5000) | SRNE / |
| Janda Kim | 0.01% (3000) | SRNE / |
UM